| Health / Medical Topics |
Tranexamic Acid
A synthetic derivative of the amino acid lysine with antifibrinolytic activity. With strong affinity for the five lysine-binding sites of plasminogen, tranexamic acid competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis; at higher concentrations, this agent noncompetitively inhibits plasmin. This agent has a longer half-life, is approximately ten times more potent, and is less toxic than aminocaproic acid, which possesses similar mechanisms of action. (NCI Thesaurus)
YOU MAY ALSO LIKE
A non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Trandolaprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin…
A non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, trandolapril is converted by de-esterification in the liver into its…
A distributed repository architecture for storing and sharing large amounts of immutable data.
A drug used alone or with dabrafenib to treat melanoma that cannot be removed by surgery or has spread to other parts…
A drug used to treat moderate to severe pain in adults. It binds to opioid receptors in the central nervous system. Tramadol…
A synthetic codeine analogue, Tramadol has central analgesic properties with effects similar to opioids, such as morphine and codeine, acting on specific…
